In the current scenario of COVID-19, Nasal Spray is considered as few of the critical products for immediate supply. But with the decline in the global supply chains of Nasal Spray/Drops, meeting the demand right on time would be challenging.
To ensure the world sustain the ever-growing demand in this time of emergency, as a prominent Nasal Spray/Drops manufacturer, you might be willing to market your product across the globe or to be specific in Poland. But do you know how Nasal Spray is classified in Poland. How the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL, Polish: Urząd Rejestracji Produktów Leczniczych) regulates Nasal Spray/Drops?
Have all your questions answered regarding:
- Nasal Spray/Drops Registration/notification in Poland
- URPL Nasal Spray/Drops Regulations
In addition, some global health authorities have already expedited their Regulatory pathways for Nasal Spray/Drops. The dynamic nature of those developments might require manufacturers to be more attentive on the regional Regulatory aspects, too. In such a case, streamline Nasal Spray/Drops global market entry with the best of regional Regulatory information and structural Regulatory approach.
As a responsible Regulatory partner, Freyr has already started assisting clients to accelerate and fast track registrations/notifications of Nasal Spray/Drops in Poland.